Trump Prepares To Reschedule Cannabis To Schedule III
President Donald Trump is expected to direct his cabinet to move forward
After weighing the “good” and the “bad,” President Donald Trump finally appears ready to direct his administration to follow through on a campaign promise to “unlock the medical uses of cannabis” as a Schedule III drug.
After holding a meeting that included cannabis industry executives on Dec. 10 in the Oval Office, Trump “is expected” to issue an executive order directing top officials in his cabinet to reclassify the plant to a less restrictive status under the Controlled Substances Act (CSA), The Washington Post reported on Thursday.
Health Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services chief Mehmet Oz also attended the meeting, while the president phoned in U.S. House Speaker Mike Johnson, R-La., who opposed the plan, arguing that several studies and data don’t support the move, the media outlet reported.
Under its current Schedule I listing alongside heroin, LSD and ecstasy as drugs with the highest potential for abuse, the federal government does not recognize cannabis as having a currently accepted medical use in the U.S. This would change under the White House’s expected plan to reschedule the plant; however, the president cannot unilaterally reschedule cannabis, and he hasn’t finalized his decision.
To Read The Rest Of This Article On Cannabis Business Times, Click Here
